Pharmacokinetics, Safety, and Tolerability of Solifenacin in Patients With Renal Insufficiency
To evaluate the pharmacokinetics, safety, and tolerability of solifenacin in patients with mild, moderate, or severe renal disease, eighteen patients with renal disease and six healthy volunteers Received a single oral dose of solifenacin (10 mg). Pharmacokinetic parameters were assessed from blood...
Main Authors: | Ronald A. Smulders, Neila N. Smith, Walter J. Smith, Timothy J. Hoon |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2007-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319343403 |
Similar Items
-
6 - Preliminary assessment of the efficacy and tolerability of solifenacin for the treatment of neurogenic overactive bladder in patients affected by multiple sclerosis
by: Eleonora Rosato, et al.
Published: (2023-06-01) -
Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients
by: Kirill Kosilov, et al.
Published: (2022-01-01) -
Patient Perception of Bladder Condition after Treatment with Solifenacin and Tolterodine in Overactive Bladder Patients
by: Tarun Pradhan, et al.
Published: (2023-03-01) -
Transcutaneous tibial neurostimulation and Solifenacin in urgent incontinence of postmenopausal women
by: Hojjat Radinmehr, et al.
Published: (2023-06-01) -
SAFETY AND EFFICACY OF THE PERONEAL ELECTRIC TRANSCUTANEOUS NEUROMODULATION (PERONEAL ETNM®) VERSUS SOLIFENACIN IN PATIENTS WITH OVERACTIVE BLADDER WET AND MIXED URINARY INCONTINENCE
by: J Krhut, et al.
Published: (2023-09-01)